Los Angeles Capital Management
MRNA icon

Los Angeles Capital Management’s Moderna MRNA Stock Holding History

Los Angeles Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$84.5K Hold
1,664
– – ﹤0.01% 1379
2025
Q4 		$46.8K Buy
+1,664
New +$45.2K ﹤0.01% 1618
2024
Q3 		– Sell
-7,614
Closed -$904K – 1251
2024
Q2 		$904K Sell
7,614
-17,660
-70% -$2.23M ﹤0.01% 684
2024
Q1 		$2.69M Buy
+25,274
New +$2.55M 0.01% 435
2023
Q3 		– Sell
-1,708
Closed -$208K – 1191
2023
Q2 		$208K Sell
1,708
-25
-1% -$3.33K ﹤0.01% 1112
2023
Q1 		$266K Sell
1,733
-32,927
-95% -$5.43M ﹤0.01% 1046
2022
Q4 		$6.23M Sell
34,660
-42,408
-55% -$6.93M 0.03% 349
2022
Q3 		$9.11M Sell
77,068
-72,955
-49% -$11.1M 0.05% 284
2022
Q2 		$21.4M Sell
150,023
-207,467
-58% -$29.7M 0.11% 174
2022
Q1 		$61.6M Buy
357,490
+239,093
+202% +$40.3M 0.24% 97
2021
Q4 		$30.1M Sell
118,397
-27,375
-19% -$8M 0.11% 162
2021
Q3 		$56.1M Sell
145,772
-95,047
-39% -$35.1M 0.26% 88
2021
Q2 		$56.6M Buy
240,819
+16,228
+7% +$2.9M 0.25% 91
2021
Q1 		$29.4M Sell
224,591
-66,612
-23% -$9.65M 0.13% 161
2020
Q4 		$30.4M Buy
291,203
+248,239
+578% +$25.1M 0.13% 143
2020
Q3 		$3.04M Sell
42,964
-8,019
-16% -$559K 0.01% 452
2020
Q2 		$3.27M Buy
+50,983
New +$2.79M 0.02% 491

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Los Angeles Capital Management's MRNA Position: Q1 2026 in Review

Los Angeles Capital Management held its Moderna (MRNA) position steady in Q1 2026 at 1,664 shares worth $84.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1379.

Los Angeles Capital Management first reported a position in MRNA in Q2 2020 and has held it in 17 quarters since. The position peaked at $61.6M in Q1 2022. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Los Angeles Capital Management held 1,664 shares of Moderna worth $84.5K as of Q1 2026.
  • Los Angeles Capital Management left its Moderna share count unchanged in Q1 2026.
  • Moderna made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1379 holding.
  • Los Angeles Capital Management first reported a position in Moderna in Q2 2020 and has held it in 17 quarters since.
  • Los Angeles Capital Management's Moderna position peaked at $61.6M in Q1 2022.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.